Loading quotes...
Forecast
There is no analyst data available for this company.
Discussions in the community
There is no discussion about this asset yet.
Start discussionNews Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Financials
| (EUR) | June 2026 | YoY |
|---|---|---|
| Revenue | 21.66k | 39.98% |
| Gross profit | 15.42k | 2.97% |
| Net profit | -127.37k | 1.07% |
| EBITDA | -106.93k | 3.54% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €3.99m |
Number of shares | 495.09m |
52-week high/low | €0.0137 - €0.00346 |
| Dividends | No |
Beta | 2.65 |
P/E ratio | -4.76 |
PEG ratio | -0.11 |
P/B ratio | 172.76 |
P/S ratio | 17.80 |
Company profile
Blueberries Medical Corp. engages in the growth, cultivation, development, production, and supply of medicinal cannabis and related products in Colombia. It offers medicinal-grade cannabis oil extracts and related products. The company is headquartered in Bogotá, Colombia.
| Name | Blueberries Medical |
| CEO | Facundo Garreton |
| Headquarters | Vancouver,
bc Canada |
| Website | |
| IPO | 09/04/2014 |
| Employees | 5 |
Deep Dive
Ticker symbols
| Exchange | Symbol |
|---|---|
Pnk | BBRRF |
Cnq | BBM.CN |
Frankfurt | 1OA.F |
MĂĽnchen | 1OA.MU |